|
|
|
|
LEADER |
01282cas a2200337 a 4500 |
001 |
8112971 |
003 |
DNLM |
005 |
20130509061326.0 |
008 |
811203d19801988xxumr p 0||| 0eng |
022 |
|
|
|a 0271-8707
|l 0271-8707
|
030 |
|
|
|a DINEE2
|
035 |
|
|
|a (DNLM)D20875000(s)
|
035 |
|
|
|a (OCoLC)06699692
|
040 |
|
|
|a DNLM
|c DNLM
|
060 |
0 |
0 |
|a W1
|b DR525
|
100 |
1 |
|
|a Hansten, Philip D.
|
222 |
|
0 |
|a Drug interactions newsletter
|
245 |
1 |
0 |
|a Drug interactions newsletter /
|c Philip D. Hansten.
|
260 |
|
|
|a San Francisco, CA :
|b Applied Therapeutics, Inc.,
|c c1980-[1988]
|
300 |
|
|
|a v.
|
310 |
|
|
|a Monthly
|
362 |
0 |
|
|a Vol. 1, no. 1-
|
362 |
1 |
|
|a Ceased with: Vol. 8, no. 10, 1988.
|
500 |
|
|
|a Title from caption.
|
500 |
|
|
|a Vol. 1, no. 1 called "Sample issue."
|
510 |
0 |
|
|9 0
|a MEDLINE
|0 Date range of indexed citations unspecified
|
510 |
0 |
|
|9 0
|a PubMed
|0 Date range of indexed citations unspecified
|
650 |
|
2 |
|a Drug Interactions
|v Periodicals.
|
999 |
|
|
|c 65449
|d 65449
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 1123257
|a M-HMOS
|b M-HMOS
|h (1993)1994-95(1996).
|o M-HMOS-1123257JNL-0271-8707
|p M-HMOS-1123257JNL-65449
|t 1606882
|y JNL
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 2162826
|a AN-BV-SSPA
|b AN-BV-SSPA
|h 1986-99, 2001-10.
|o AN-BV-SSPA-2162826JNL-0271-8707
|p AN-BV-SSPA-2162826JNL-65449
|t 2867691
|y JNL
|